New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Identification of three genes that determine the stemness of gastric tissue stem cells

Identification of three genes that determine the stemness of gastric tissue stem cells

A. Outline of GeCKO screening using organoids. Gastric organoids are established from mice that allow visualization of tissue stem cells; genes are randomly rendered loss-of-function by introducing a
World medicine November 02,2023
Identification of three genes that determine the stemness of gastric tissue stem cells

Identification of three genes that determine the stemness of gastric tissue stem cells

A. Outline of GeCKO screening using organoids. Gastric organoids are established from mice that allow visualization of tissue stem cells; genes are randomly rendered loss-of-function by introducing a
World medicine November 02,2023
UC San Diego Health treats first cancer patient with stem-cell derived natural killer cells

UC San Diego Health treats first cancer patient with stem-cell derived natural killer cells

After 10 years in remission, Derek Ruff's cancer returned, this time as stage IV colon cancer. Despite aggressive rounds of chemotherapy, palliative radiotherapy and immunotherapy, his disease pro
World medicine November 02,2023
UC San Diego Health treats first cancer patient with stem-cell derived natural killer cells

UC San Diego Health treats first cancer patient with stem-cell derived natural killer cells

After 10 years in remission, Derek Ruff's cancer returned, this time as stage IV colon cancer. Despite aggressive rounds of chemotherapy, palliative radiotherapy and immunotherapy, his disease pro
World medicine November 02,2023
A stem cell based cell culture model for nonalcoholic fatty liver disease

A stem cell based cell culture model for nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long
World medicine November 02,2023
A stem cell based cell culture model for nonalcoholic fatty liver disease

A stem cell based cell culture model for nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long
World medicine November 02,2023
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

More than 60 percent of patients with Epstein-Barr virus–associated lymphoproliferative disorder (EBV-LPD) that was not responding to standard rituximab (Rituxan) treatment responded to a new type of
World medicine November 02,2023
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

More than 60 percent of patients with Epstein-Barr virus–associated lymphoproliferative disorder (EBV-LPD) that was not responding to standard rituximab (Rituxan) treatment responded to a new type of
World medicine November 02,2023
Gene family turns cancer cells into aggressive stem cells that keep growing

Gene family turns cancer cells into aggressive stem cells that keep growing

An examination of 130 gene expression studies in 10 solid cancers has found that when any of four related genes is overexpressed, patients have much worse outcomes, including reduced survival.Research
World medicine November 02,2023
Gene family turns cancer cells into aggressive stem cells that keep growing

Gene family turns cancer cells into aggressive stem cells that keep growing

An examination of 130 gene expression studies in 10 solid cancers has found that when any of four related genes is overexpressed, patients have much worse outcomes, including reduced survival.Research
World medicine November 02,2023
Dormant neural stem cells in fruit flies activate to generate new brain cells

Dormant neural stem cells in fruit flies activate to generate new brain cells

A new research study by Duke-NUS Medical School describes how dormant neural stem cells in fruit flies are activated and generate new neurons. The findings could potentially help people with brain inj
World medicine November 02,2023
Dormant neural stem cells in fruit flies activate to generate new brain cells

Dormant neural stem cells in fruit flies activate to generate new brain cells

A new research study by Duke-NUS Medical School describes how dormant neural stem cells in fruit flies are activated and generate new neurons. The findings could potentially help people with brain inj
World medicine November 02,2023
Mutations in bone cells can drive leukemia in neighboring stem cells

Mutations in bone cells can drive leukemia in neighboring stem cells

Certain DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells, researchers from Winship Cancer Institute, Emory University and Children&#39
Oncology November 02,2023
Mutations in bone cells can drive leukemia in neighboring stem cells

Mutations in bone cells can drive leukemia in neighboring stem cells

Certain DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells, researchers from Winship Cancer Institute, Emory University and Children&#39
Oncology November 02,2023
Engineered natural killer cells can eliminate glioblastoma stem cells

Engineered natural killer cells can eliminate glioblastoma stem cells

Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immu
World medicine November 02,2023
Engineered natural killer cells can eliminate glioblastoma stem cells

Engineered natural killer cells can eliminate glioblastoma stem cells

Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immu
World medicine November 02,2023
Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis
Diabetes & Endocrinology November 02,2023
Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis
Diabetes & Endocrinology November 02,2023
Stem cells either overproduce or underproduce brain cells in autism patients

Stem cells either overproduce or underproduce brain cells in autism patients

Credit: CC0 Public DomainAnalyzing brain stem cells of patients with autism spectrum disorder (ASD), Rutgers scientists have found evidence of irregularities in very early brain development that may c
Psychiatry & Mental Health November 02,2023
Stem cells either overproduce or underproduce brain cells in autism patients

Stem cells either overproduce or underproduce brain cells in autism patients

Credit: CC0 Public DomainAnalyzing brain stem cells of patients with autism spectrum disorder (ASD), Rutgers scientists have found evidence of irregularities in very early brain development that may c
Psychiatry & Mental Health November 02,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com